ZILA BIOTECHNOLOGY INC has a total of 41 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, United States and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are BLUM KENNETH, PINTEX PHARMACEUTICALS INC and FUJIAN ACAD OF MEDICAL SCIENCES.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 11 | |
#2 | United States | 5 | |
#3 | Republic of Korea | 4 | |
#4 | Norway | 4 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Mexico | 2 | |
#8 | Taiwan | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | Argentina | 1 | |
#11 | Brazil | 1 | |
#12 | Chile | 1 | |
#13 | Israel | 1 | |
#14 | New Zealand | 1 | |
#15 | Poland | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Measuring microorganism processes | |
#3 | Therapeutic chemical compounds | |
#4 | Diagnosis and surgery | |
#5 | Heterocyclic compounds | |
#6 | Analysing materials | |
#7 | Pigments |
# | Name | Total Patents |
---|---|---|
#1 | Burkett Douglas D | 35 |
#2 | Chiafari Francis A | 5 |
#3 | Bride Mark | 5 |
#4 | Sidransky David | 5 |
#5 | Allen Antonette C P | 5 |
#6 | Maguire Yu Ping | 5 |
#7 | Okolotowicz Karl | 4 |
#8 | Bernal Samuel D | 2 |
#9 | Rose Seth D | 2 |
#10 | Green Ralph E | 2 |
Publication | Filing date | Title |
---|---|---|
US2009023138A1 | Oral cancer markers and their detection | |
KR20070106974A | Light-directed method for detecting and aiding further evaluation of abnormal mucosal tissue | |
ZA200703097B | Light-directed method for detecting and aiding further evaluation of abnormal mucosal tissue | |
AU2004324049A1 | Light-directed method for detecting and aiding further evaluation of abnormal mucosal tissue | |
AU2002347835A1 | Light-directed molecular analysis for cancer prognosis and diagnosis | |
KR20050044769A | Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues | |
NZ537344A | Toluidine blue O drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues | |
AU2001288456B2 | Light-stabilized $I(in vivo) stain composition and method of manufacture | |
US7462346B2 | Light-stabilized(in vivo) stain composition and method of manufacture |